Miromatrix Medical Inc. (MIRO)
Dec 13, 2023 - MIRO was delisted (reason: acquired by United Therapeutics)
3.390
0.00 (0.00%)
Inactive · Last trade price
on Dec 12, 2023
Company Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs.
The company's proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells.
It has collaborations with Baxter, CareDx, The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute.
The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Miromatrix Medical Inc.
| Country | United States |
| Founded | 2009 |
| IPO Date | Jun 24, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Dr. Jeffrey James Ross Ph.D. |
Contact Details
Address: 6455 Flying Cloud Drive, Suite 107 Eden Prairie, Minnesota 55344 | |
| Phone | (612)202-7026 |
| Website | miromatrix.com |
Stock Details
| Ticker Symbol | MIRO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $9.00 |
| CIK Code | 0001527096 |
| CUSIP Number | 60471P108 |
| ISIN Number | US60471P1084 |
| Employer ID | 27-1285782 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey James Ross Ph.D. | Chief Executive Officer and Director |
| Brian D. Niebur CPA | Chief Financial Officer and Vice President of Finance |
| James M. Douglas | Chief Financial Officer and Secretary |
| Tom Emig | Vice President of People and Culture |
| Dr. John Joseph Barry Ph.D. | Vice President of Research & Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 13, 2023 | POS AM | Post-Effective amendments for registration statement |
| Dec 13, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Dec 13, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Dec 13, 2023 | SC 14D9/A | Filing |
| Dec 13, 2023 | SC TO-T/A | Filing |
| Dec 13, 2023 | 25-NSE | Filing |
| Dec 12, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Dec 12, 2023 | SC 14D9/A | Filing |
| Dec 12, 2023 | SC TO-T/A | Filing |
| Dec 7, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |